Sun Pharma and Lupin Post Record Results as Dr Reddy’s Takes ₹240 Crore Semaglutide Hit in Q1 FY27
Sun Pharma posted ₹2,895 crore profit (+27%) and Lupin set a revenue record in Q1 FY27, while Dr Reddy's profit fell 69% on a ₹240 crore semaglutide API write-down and Cipla's margins

Follow